LCH Names Daniel Maguire as CEO
Clearinghouse COO steps up to CEO position as Suneel Bakhshi takes on LSEG chairman's role.

Maguire was appointed LCH Group COO in April this year, as well as holding the role of global head of rates and foreign-exchange (FX) derivatives since March 2014. He will also become a member of London Stock Exchange Group’s executive committee, reporting to Xavier Rolet, LSEG CEO.
“Daniel brings extensive experience to the role, having been part of the senior management team leading the growth of our global OTC clearing services, delivering innovative solutions in an environment of LCH’s focus on best-in-class risk management and operational resiliency,” said Lex Hoogduin, chairman of LCH Group, in a statement.
Commenting on his new role, Maguire said: “The role of the clearing house has never been more relevant, helping to reduce risk and improve operational efficiency in financial markets, and I look forward to working with members and their clients as we continue to grow the Group’s global business.”
Bakhshi, who announced in summer this year his intention to step down as CEO after four years at the LCH helm, will take on the role of chairman for LSEG International Advisory Groups.
Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.
To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: https://subscriptions.waterstechnology.com/subscribe
You are currently unable to print this content. Please contact info@waterstechnology.com to find out more.
You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.
Copyright Infopro Digital Limited. All rights reserved.
As outlined in our terms and conditions, https://www.infopro-digital.com/terms-and-conditions/subscriptions/ (point 2.4), printing is limited to a single copy.
If you would like to purchase additional rights please email info@waterstechnology.com
Copyright Infopro Digital Limited. All rights reserved.
You may share this content using our article tools. As outlined in our terms and conditions, https://www.infopro-digital.com/terms-and-conditions/subscriptions/ (clause 2.4), an Authorised User may only make one copy of the materials for their own personal use. You must also comply with the restrictions in clause 2.5.
If you would like to purchase additional rights please email info@waterstechnology.com
More on Emerging Technologies
BofA ramps up AI deployment, patents
The bank has 1,400 patents in AI and machine learning, either granted or pending, alongside a growing portfolio of 250 models.
BNY CEO updates on ‘platform’ operating model, AI rollout
In its Q2 earnings call, the bank outlined its progress on rolling out its new operating model and ‘Eliza’ internal AI assistant.
NZX outlines plans to bolster fast-growing dark pool
Since launching one year ago, NZX’s dark book has 5.5% of the exchange’s total turnover, and price improvement per trade on average is 11 basis points, but the exchange has more in store.
Waters Wavelength Ep. 325: Octaura’s Brian Bejile
The CEO joins the podcast to talk about the vendor’s modernization efforts in credit and CLOs.
Agentic AI comes to Bloomberg Terminal via Anthropic protocol
The data giant’s ubiquitous terminal has been slowly opening up for years, but its latest enhancement represents a forward leap in what CTO Shawn Edwards calls, “the way we should talk to the world.”
M&G Investments braves cost headwinds in pursuit of AI
The UK asset manager’s AI ambitions started with the creation of a data lake to ensure high-quality data is being fed into models.
Droit awarded patent, US CT plan shapes up, Chicago traders go to court, and more
The Waters Cooler: TNS expands 24x5 trading, SIX and Pictet complete a token pilot, and an Asic probe spells more trouble for ASX in this week’s news roundup.
GenAI too risky for collateral processes
The technology has been heralded as game-changing for other areas of finance, but its potential to hallucinate may disqualify it from sensitive settlement procedures.